The Corporate Strategy and Development team at Spyre Therapeutics oversees the strategic planning and execution of business initiatives, including mergers and acquisitions, partnerships, and corporate growth opportunities. They ensure alignment across preclinical and clinical development efforts, operational optimization, and contractual agreements to advance the company's innovative treatments for inflammatory bowel disease.
View all